Najma Rachidi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Najma Rachidi has a total of 169 co-authors. Here are the top co-authors by number of shared publications:
- Gerald Frank Spaeth
Institut Pasteur
13 shared publications - Olivier Leclercq
Unité de Parasitologie Moléculaire et Signalisation, Institut Pasteur and INSERM U1201, F-75015 Paris, France
7 shared publications - Eric Prina
Institut Pasteur
6 shared publications Damarys Loew
Laboratoire de Spectrométrie de Masse Protéomique (LSMP), Centre de Recherche, Institut Curie, PSL Research University, Paris, France
5 shared publicationsGerald F. Späth
Institut Pasteur, Université de Paris, Institut National de Santé et Recherche Médicale INSERM U1201, Unité de parasitologie Moléculaire et Signalisation, Paris, France
5 shared publications- Michael J. R. Stark
Centre for Gene Regulation & Expression, College of Life Sciences, MSI/WTB Complex, University of Dundee, Dundee DD1 5EH, Scotland, UK
5 shared publications
Latest Publications
- Open Access
- 5 October 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (10) , e0356818
Characterization of the dual functions of Leishmania CK1.2 in both the parasite and the macrophage
Leishmania CK1.2 (L-CK1.2) is a serine/threonine protein kinase essential for the survival of the protozoan parasite Leishmania , the causative agent of leishmaniasis. This study investigates the dynamic localization pattern of L-CK1.2 and the broad spectrum of its interacting partners within the parasite. Using proteomic analysis and confocal microscopy, we identified 230 L-CK1.2-associated proteins across the major parasite life stages. This analysis revealed the ubiquitous presence of L-CK1.2 in various cellular structures, including the cytoskeleton, basal body, and flagellum. Using an in vitro system, sixty-four host proteins, involved in critical host biological processes such as immune response, apoptosis, and purine biosynthesis, were identified as potential interacting partners of L-CK1.2. These processes are known to be regulated by Leishmania during infection. The study highlights the potential dual function of L-CK1.2, in the parasite ( cis ) and within the host cell ( trans ), positioning this kinase as a key player in host-pathogen interactions. This work provides a comprehensive map of L-CK1.2 interactions and suggests its potential importance in regulating intracellular Leishmania survival, providing potential targets for leishmaniasis therapy. Furthermore, given the evolutionary conservation of CK1.2 across other parasitic organisms, our findings may have broader implications for understanding and managing parasitic infections.
- 5 October 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (10) , e0356818
Open AccessCharacterization of the dual functions of Leishmania CK1.2 in both the parasite and the macrophage
Leishmania CK1.2 (L-CK1.2) is a serine/threonine protein kinase essential for the survival of the protozoan parasite Leishmania , the causative agent of leishmaniasis. This study investigates the dynamic localization pattern of L-CK1.2 and the broad spectrum of its interacting partners within the parasite. Using proteomic analysis and confocal microscopy, we identified 230 L-CK1.2-associated proteins across the major parasite life stages. This analysis revealed the ubiquitous presence of L-CK1.2 in various cellular structures, including the cytoskeleton, basal body, and flagellum. Using an in vitro system, sixty-four host proteins, involved in critical host biological processes such as immune response, apoptosis, and purine biosynthesis, were identified as potential interacting partners of L-CK1.2. These processes are known to be regulated by Leishmania during infection. The study highlights the potential dual function of L-CK1.2, in the parasite ( cis ) and within the host cell ( trans ), positioning this kinase as a key player in host-pathogen interactions. This work provides a comprehensive map of L-CK1.2 interactions and suggests its potential importance in regulating intracellular Leishmania survival, providing potential targets for leishmaniasis therapy. Furthermore, given the evolutionary conservation of CK1.2 across other parasitic organisms, our findings may have broader implications for understanding and managing parasitic infections.
- Open Access
Dynamic phosphoproteomics and proteomics uncover Leishmania donovani -driven ferritin hijacking, contributing to the control of iron homeostasis and iron-related oxidative stress
Leishmania donovani , the causative agent of visceral leishmaniasis, survives within the parasitophorous vacuole (PV) of mammalian macrophages by extensively rewiring host cellular pathways. Although transcriptional and proteomic changes in infected macrophages have been characterized, the impact on the host phosphoproteome, a pivotal, reversible regulator of signalling, remains largely unexplored. To address this gap, we combined time-resolved quantitative phosphoproteomics and proteomics to map the dynamic response of murine macrophages to L. donovani infection. Early after infection, the parasite rapidly attenuates the macrophage signaling cascades normally triggered by phagocytosis. Between 24 h and 48 h post-infection we observed a progressive de-phosphorylation of proteins involved in innate immunity, apoptosis and other stress-responsive pathways, consistent with a partial shutdown of multiple host kinases. From 24 h onward, a global decline in protein abundance was also detected, most notably within lysosomal network. Strikingly, only five host proteins were consistently up-regulated, suggesting their importance for parasite survival. Ferritin light chain (Ftl1) displayed the largest increase. Immunofluorescence and transmission-electron microscopy revealed that Ftl1 accumulates within the parasitophorous vacuole, colocalizes with the ferritin receptor Ncoa4, and yet fails to undergo degradation, indicating that Leishmania co-opts ferritin as its own intracellular iron-storage compartment. Ferritin is not confined to the PV; it is also internalized by the parasite. Within L. donovani , ferritin accumulates not only in the cytoplasm but also in the nucleus, where it may function both as an iron-storage depot and as an iron buffer that protects the parasite from oxidative damage. Finally, we demonstrate that Leishmania donovani pre-conditions its host macrophage for the iron-rich environments of the liver and spleen by driving the assembly of ferritin particles enriched in ferritin-light chain. This contrasts with L. amazonensis , which, residing in the iron-poor skin, induces ferritin predominated by ferritin-heavy chain (Fth1). Knock-down of Ftl1 did not decrease parasite survival because macrophages compensated for its loss by up-regulating Hspb1 , which encodes a protein that limits lipid peroxidation by inhibiting the Fenton reaction. Although this response protects the host cell, it also diminishes iron import, imposing a metabolic cost on Leishmania . Hspb1 represents only one example; additional, as yet unidentified, compensatory pathways are likely activated by the parasite to mitigate the loss of ferritin-light chain. Collectively, our data uncover a previously unknown strategy whereby L. donovani hijacks host ferritin trafficking to create a protected iron reservoir, thereby preventing ferroptosis. This mechanism sets Leishmania , a eukaryotic intracellular parasite, apart from the canonical iron-acquisition tactics employed by bacteria and fungi.
Open AccessDynamic phosphoproteomics and proteomics uncover Leishmania donovani -driven ferritin hijacking, contributing to the control of iron homeostasis and iron-related oxidative stress
Leishmania donovani , the causative agent of visceral leishmaniasis, survives within the parasitophorous vacuole (PV) of mammalian macrophages by extensively rewiring host cellular pathways. Although transcriptional and proteomic changes in infected macrophages have been characterized, the impact on the host phosphoproteome, a pivotal, reversible regulator of signalling, remains largely unexplored. To address this gap, we combined time-resolved quantitative phosphoproteomics and proteomics to map the dynamic response of murine macrophages to L. donovani infection. Early after infection, the parasite rapidly attenuates the macrophage signaling cascades normally triggered by phagocytosis. Between 24 h and 48 h post-infection we observed a progressive de-phosphorylation of proteins involved in innate immunity, apoptosis and other stress-responsive pathways, consistent with a partial shutdown of multiple host kinases. From 24 h onward, a global decline in protein abundance was also detected, most notably within lysosomal network. Strikingly, only five host proteins were consistently up-regulated, suggesting their importance for parasite survival. Ferritin light chain (Ftl1) displayed the largest increase. Immunofluorescence and transmission-electron microscopy revealed that Ftl1 accumulates within the parasitophorous vacuole, colocalizes with the ferritin receptor Ncoa4, and yet fails to undergo degradation, indicating that Leishmania co-opts ferritin as its own intracellular iron-storage compartment. Ferritin is not confined to the PV; it is also internalized by the parasite. Within L. donovani , ferritin accumulates not only in the cytoplasm but also in the nucleus, where it may function both as an iron-storage depot and as an iron buffer that protects the parasite from oxidative damage. Finally, we demonstrate that Leishmania donovani pre-conditions its host macrophage for the iron-rich environments of the liver and spleen by driving the assembly of ferritin particles enriched in ferritin-light chain. This contrasts with L. amazonensis , which, residing in the iron-poor skin, induces ferritin predominated by ferritin-heavy chain (Fth1). Knock-down of Ftl1 did not decrease parasite survival because macrophages compensated for its loss by up-regulating Hspb1 , which encodes a protein that limits lipid peroxidation by inhibiting the Fenton reaction. Although this response protects the host cell, it also diminishes iron import, imposing a metabolic cost on Leishmania . Hspb1 represents only one example; additional, as yet unidentified, compensatory pathways are likely activated by the parasite to mitigate the loss of ferritin-light chain. Collectively, our data uncover a previously unknown strategy whereby L. donovani hijacks host ferritin trafficking to create a protected iron reservoir, thereby preventing ferroptosis. This mechanism sets Leishmania , a eukaryotic intracellular parasite, apart from the canonical iron-acquisition tactics employed by bacteria and fungi.
- Open Access
Characterization of the dual functions of Leishmania CK1.2 in both the parasite and the macrophage
Leishmania CK1.2 (L-CK1.2) is a serine/threonine protein kinase essential for the survival of the protozoan parasite Leishmania , the causative agent of Leishmaniasis. This study investigates the dynamic localization pattern of L-CK1.2 and the broad spectrum of its interacting partners within the parasite. Using proteomic analysis and confocal microscopy, we identified 230 L-CK1.2-associated proteins across the parasite life stages, promastigotes (in the insect vector), and amastigotes, (in the phagolysosomes of host macrophages). This analysis revealed the ubiquitous presence of L-CK1.2 in various cellular structures, including the cytoskeleton, basal body, and flagellum. Using an in vitro system, sixty-four host L-CK1.2-associated proteins, involved in critical host biological processes such as immune response, apoptosis, and purine biosynthesis, were shown to interact with L-CK1.2. These processes are known to be regulated by Leishmania during infection. The study highlights the dual function of L-CK1.2, in the parasite (cis) and within the host cell (trans), positioning this kinase as a key player in host-pathogen interactions. This work provides a comprehensive map of L-CK1.2 interactions and suggest its potential importance in regulating intracellular Leishmania survival, providing potential therapeutic targets for Leishmaniasis. Furthermore, given the evolutionary conservation of CK1.2 across other parasitic organisms, our findings may have broader implications for understanding and managing parasitic infections.
Open AccessCharacterization of the dual functions of Leishmania CK1.2 in both the parasite and the macrophage
Leishmania CK1.2 (L-CK1.2) is a serine/threonine protein kinase essential for the survival of the protozoan parasite Leishmania , the causative agent of Leishmaniasis. This study investigates the dynamic localization pattern of L-CK1.2 and the broad spectrum of its interacting partners within the parasite. Using proteomic analysis and confocal microscopy, we identified 230 L-CK1.2-associated proteins across the parasite life stages, promastigotes (in the insect vector), and amastigotes, (in the phagolysosomes of host macrophages). This analysis revealed the ubiquitous presence of L-CK1.2 in various cellular structures, including the cytoskeleton, basal body, and flagellum. Using an in vitro system, sixty-four host L-CK1.2-associated proteins, involved in critical host biological processes such as immune response, apoptosis, and purine biosynthesis, were shown to interact with L-CK1.2. These processes are known to be regulated by Leishmania during infection. The study highlights the dual function of L-CK1.2, in the parasite (cis) and within the host cell (trans), positioning this kinase as a key player in host-pathogen interactions. This work provides a comprehensive map of L-CK1.2 interactions and suggest its potential importance in regulating intracellular Leishmania survival, providing potential therapeutic targets for Leishmaniasis. Furthermore, given the evolutionary conservation of CK1.2 across other parasitic organisms, our findings may have broader implications for understanding and managing parasitic infections.
- 5 June 2025
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 16 (8) , 3746-3763
Pharmacophore-guided optimization of the hit compound CTN1122 in the design of promising imidazo[1,2-a]pyrazine derivatives targeting the casein kinase 1 for antileishmanial therapy
Our research group identified CTN1122, an imidazo[1,2-a]pyrazine derivative, as a promising antileishmanial agent targeting intramacrophage amastigotes of Leishmania major and Leishmania donovani. CTN1122 selectively inhibits Leishmania casein kinase 1 (L-CK1.2) with a favorable safety profile. Docking studies based on a homology model highlighted key pharmacophoric elements: a 4-pyridyl group at C3, crucial for hydrogen bonding with leucine 90 in the ATP-binding site, and a 4-fluorophenyl moiety at C2, fitting into a hydrophobic pocket. In order to validate these findings, 14 analogs were synthesized with targeted modifications on the imidazo[1,2-a]pyrazine core structure. Three probed the C8 position, three evaluated the impact of C2 substitution, six assessed the C3 4-pyridyl group, and two combined changes at C8 and C3. The study confirmed the critical role of C2 and C3 substituents, as their absence significantly reduced L-CK1.2 inhibition and antileishmanial activity. Additionally, the nitrogen's position within the pyridine ring at C3 proved essential: compound 23, with a meta-pyridyl group, was inactive. Notably, compound 30 exhibited the highest antileishmanial in vitro potency (IC50 = 0.20 μM for L. major; 0.16 μM for L. donovani) alongside enhanced L-CK1.2 inhibition (IC50 = 0.384 μM), with no significant mammalian cytotoxicity.
- 5 June 2025
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 16 (8) , 3746-3763
Pharmacophore-guided optimization of the hit compound CTN1122 in the design of promising imidazo[1,2-a]pyrazine derivatives targeting the casein kinase 1 for antileishmanial therapy
Our research group identified CTN1122, an imidazo[1,2-a]pyrazine derivative, as a promising antileishmanial agent targeting intramacrophage amastigotes of Leishmania major and Leishmania donovani. CTN1122 selectively inhibits Leishmania casein kinase 1 (L-CK1.2) with a favorable safety profile. Docking studies based on a homology model highlighted key pharmacophoric elements: a 4-pyridyl group at C3, crucial for hydrogen bonding with leucine 90 in the ATP-binding site, and a 4-fluorophenyl moiety at C2, fitting into a hydrophobic pocket. In order to validate these findings, 14 analogs were synthesized with targeted modifications on the imidazo[1,2-a]pyrazine core structure. Three probed the C8 position, three evaluated the impact of C2 substitution, six assessed the C3 4-pyridyl group, and two combined changes at C8 and C3. The study confirmed the critical role of C2 and C3 substituents, as their absence significantly reduced L-CK1.2 inhibition and antileishmanial activity. Additionally, the nitrogen's position within the pyridine ring at C3 proved essential: compound 23, with a meta-pyridyl group, was inactive. Notably, compound 30 exhibited the highest antileishmanial in vitro potency (IC50 = 0.20 μM for L. major; 0.16 μM for L. donovani) alongside enhanced L-CK1.2 inhibition (IC50 = 0.384 μM), with no significant mammalian cytotoxicity.
- 6 January 2025
- Published by Wiley in ChemMedChem
- Vol. 20 (6) , e202400862
Investigating the C2 Modulation of the Imidazo[1,2‐a]pyrazine‐Based Hit Compound CTN1122: Synthesis, in vitro Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition
Our research group previously discovered CTN1122, an imidazo[1,2‐a]pyrazine compound with promising antileishmanial activity against intramacrophage amastigotes of Leishmania major and L. donovani strains. CTN1122 effectively targets Leishmania casein kinase 1 (L–CK1.2) and exhibits a favorable safety profile. To further explore its chemical space, we developed a convergent strategy to modify the C2 position of the imidazo[1,2‐a]pyrazine core using Suzuki‐Miyaura coupling of the corresponding triflate intermediate. Among 15 newly synthesized analogs, seven derivatives featuring variously substituted phenyl rings at C2 demonstrated L–CK1.2 inhibition within micromolar to submicromolar ranges and antileishmanial activity in vitro with low cytotoxicity in macrophages. Compounds 7 d and 7 l were particularly potent, with IC50 values of 1.25 μM and 0.92 μM against L. major, and 1.44 μM and 2.34 μM against L. donovani, respectively. They showed IC50 L–CK1.2=0.30 μM and 0.57 μM with enhanced selectivity indices (SI=3.8 and 1.6) over the human CK1ϵ ortholog. Additionally, four C2 analogs and two C5 isomers exhibited notable antiparasitic effects without strongly inhibiting L–CK1.2, indicating a possible alternative mechanism of action. Compound 7 k displayed the highest general activity, with IC50 values of 0.31 μM on L. major and 0.27 μM on L. donovani, coupled with favorable selectivity indexes.
- 6 January 2025
- Published by Wiley in ChemMedChem
- Vol. 20 (6) , e202400862
Investigating the C2 Modulation of the Imidazo[1,2‐a]pyrazine‐Based Hit Compound CTN1122: Synthesis, in vitro Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition
Our research group previously discovered CTN1122, an imidazo[1,2‐a]pyrazine compound with promising antileishmanial activity against intramacrophage amastigotes of Leishmania major and L. donovani strains. CTN1122 effectively targets Leishmania casein kinase 1 (L–CK1.2) and exhibits a favorable safety profile. To further explore its chemical space, we developed a convergent strategy to modify the C2 position of the imidazo[1,2‐a]pyrazine core using Suzuki‐Miyaura coupling of the corresponding triflate intermediate. Among 15 newly synthesized analogs, seven derivatives featuring variously substituted phenyl rings at C2 demonstrated L–CK1.2 inhibition within micromolar to submicromolar ranges and antileishmanial activity in vitro with low cytotoxicity in macrophages. Compounds 7 d and 7 l were particularly potent, with IC50 values of 1.25 μM and 0.92 μM against L. major, and 1.44 μM and 2.34 μM against L. donovani, respectively. They showed IC50 L–CK1.2=0.30 μM and 0.57 μM with enhanced selectivity indices (SI=3.8 and 1.6) over the human CK1ϵ ortholog. Additionally, four C2 analogs and two C5 isomers exhibited notable antiparasitic effects without strongly inhibiting L–CK1.2, indicating a possible alternative mechanism of action. Compound 7 k displayed the highest general activity, with IC50 values of 0.31 μM on L. major and 0.27 μM on L. donovani, coupled with favorable selectivity indexes.
- Open Access
- 17 February 2022
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 12, 825458
Released Parasite-Derived Kinases as Novel Targets for Antiparasitic Therapies
The efficient manipulation of their host cell is an essential feature of intracellular parasites. Most molecular mechanisms governing the subversion of host cell by protozoan parasites involve the release of parasite-derived molecules into the host cell cytoplasm and direct interaction with host proteins. Among these released proteins, kinases are particularly important as they govern the subversion of important host pathways, such as signalling or metabolic pathways. These enzymes, which catalyse the transfer of a phosphate group from ATP onto serine, threonine, tyrosine or histidine residues to covalently modify proteins, are involved in numerous essential biological processes such as cell cycle or transport. Although little is known about the role of most of the released parasite-derived kinases in the host cell, they are examples of kinases hijacking host cellular pathways such as signal transduction or apoptosis, which are essential for immune response evasion as well as parasite survival and development. Here we present the current knowledge on released protozoan kinases and their involvement in host-pathogen interactions. We also highlight the knowledge gaps remaining before considering those kinases - involved in host signalling subversion - as antiparasitic drug targets.
- 17 February 2022
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 12, 825458
Open AccessReleased Parasite-Derived Kinases as Novel Targets for Antiparasitic Therapies
The efficient manipulation of their host cell is an essential feature of intracellular parasites. Most molecular mechanisms governing the subversion of host cell by protozoan parasites involve the release of parasite-derived molecules into the host cell cytoplasm and direct interaction with host proteins. Among these released proteins, kinases are particularly important as they govern the subversion of important host pathways, such as signalling or metabolic pathways. These enzymes, which catalyse the transfer of a phosphate group from ATP onto serine, threonine, tyrosine or histidine residues to covalently modify proteins, are involved in numerous essential biological processes such as cell cycle or transport. Although little is known about the role of most of the released parasite-derived kinases in the host cell, they are examples of kinases hijacking host cellular pathways such as signal transduction or apoptosis, which are essential for immune response evasion as well as parasite survival and development. Here we present the current knowledge on released protozoan kinases and their involvement in host-pathogen interactions. We also highlight the knowledge gaps remaining before considering those kinases - involved in host signalling subversion - as antiparasitic drug targets.
- Open Access
- 3 January 2022
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 9, 800098
Identification of the Host Substratome of Leishmania-Secreted Casein Kinase 1 Using a SILAC-Based Quantitative Mass Spectrometry Assay
Leishmaniasis is a severe public health problem, caused by the protozoanLeishmania. This parasite has two developmental forms, extracellular promastigote in the insect vector and intracellular amastigote in the mammalian host where it resides inside the phagolysosome of macrophages. Little is known about the virulence factors that regulate host-pathogen interactions and particularly host signalling subversion. All the proteomes ofLeishmaniaextracellular vesicles identified the presence ofLeishmaniacasein kinase 1 (L-CK1.2), a signalling kinase. L-CK1.2 is essential for parasite survival and thus might be essential for host subversion. To get insights into the functions of L-CK1.2 in the macrophage, the systematic identification of its host substrates is crucial, we thus developed an easy method to identify substrates, combining phosphatase treatment,in vitrokinase assay and Stable Isotope Labelling with Amino acids in Cell (SILAC) culture-based mass spectrometry. Implementing this approach, we identified 225 host substrates as well as a potential novel phosphorylation motif for CK1. We confirmed experimentally the enrichment of our substratome in bona fide L-CK1.2 substrates and showed they were also phosphorylated by human CK1δ. L-CK1.2 substratome is enriched in biological processes such as “viral and symbiotic interaction,” “actin cytoskeleton organisation” and “apoptosis,” which are consistent with the host pathways modified byLeishmaniaupon infection, suggesting that L-CK1.2 might be the missing link. Overall, our results generate important mechanistic insights into the signalling of host subversion by these parasites and other microbial pathogens adapted for intracellular survival.
- 3 January 2022
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 9, 800098
Open AccessIdentification of the Host Substratome of Leishmania-Secreted Casein Kinase 1 Using a SILAC-Based Quantitative Mass Spectrometry Assay
Leishmaniasis is a severe public health problem, caused by the protozoanLeishmania. This parasite has two developmental forms, extracellular promastigote in the insect vector and intracellular amastigote in the mammalian host where it resides inside the phagolysosome of macrophages. Little is known about the virulence factors that regulate host-pathogen interactions and particularly host signalling subversion. All the proteomes ofLeishmaniaextracellular vesicles identified the presence ofLeishmaniacasein kinase 1 (L-CK1.2), a signalling kinase. L-CK1.2 is essential for parasite survival and thus might be essential for host subversion. To get insights into the functions of L-CK1.2 in the macrophage, the systematic identification of its host substrates is crucial, we thus developed an easy method to identify substrates, combining phosphatase treatment,in vitrokinase assay and Stable Isotope Labelling with Amino acids in Cell (SILAC) culture-based mass spectrometry. Implementing this approach, we identified 225 host substrates as well as a potential novel phosphorylation motif for CK1. We confirmed experimentally the enrichment of our substratome in bona fide L-CK1.2 substrates and showed they were also phosphorylated by human CK1δ. L-CK1.2 substratome is enriched in biological processes such as “viral and symbiotic interaction,” “actin cytoskeleton organisation” and “apoptosis,” which are consistent with the host pathways modified byLeishmaniaupon infection, suggesting that L-CK1.2 might be the missing link. Overall, our results generate important mechanistic insights into the signalling of host subversion by these parasites and other microbial pathogens adapted for intracellular survival.
- Open Access
SILAKin: A novel high throughput SILAC and mass spectrometry-based assay to identify the substratome of kinases secreted by pathogens
Protein phosphorylation is one of the most important reversible post-translational modifications. It affects every cellular process including differentiation, metabolism and cell cycle. Eukaryotic protein kinases (ePK) catalyse the transfer of a phosphate from ATP onto proteins, which regulates fast changes in protein activity, structure or subcellular localisation. The systematic identification of substrates is thus crucial to characterise the functions of kinases and determine the pathways they regulate, and even more so when studying the impact of pathogens-excreted kinases on the host cell signal transduction. Several strategies and approaches have been used to identify substrates, but all show important limitations thus calling for the development of new efficient and more convenient approaches for kinase substrate identification. Herein, we present SILAkin, a novel and easy method to identify substrates that is applicable to most kinases. It combines phosphatase treatment, pulse heating, in vitro kinase assay (IVKA) and SILAC (Stable Isotope Labeling with Amino acids in Cell culture)-based quantitative mass spectrometry (MS). We developed SILAkin using the Leishmania casein kinase 1 (L-CK1.2) as experimental model. Leishmania , an intracellular parasite causing Leishmaniasis, releases L-CK1.2 in its host cell. Applying this novel assay allowed us to gain unprecedented insight into host-pathogen interactions through the identification of host substrates phosphorylated by pathogen-excreted kinases. We identified 225 substrates, including 85% previously unknown that represent novel mammalian CK1 targets, and defined a novel CK1 phosphorylation motif. The substratome was validated experimentally by L-CK1.2 and human CK1δ, demonstrating the efficiency of SILAkin to identify new substrates and revealing novel regulatory pathways. Finally, SILAkin was instrumental in highlighting host pathways potentially regulated by L-CK1.2 in Leishmania- infected host cells, described by the GO terms ‘viral & symbiotic interaction’, ‘apoptosis’, ‘actin cytoskeleton organisation’, and ‘RNA processing and splicing’. SILAkin thus can generate important mechanistic insights into the signalling of host subversion by these parasites and other microbial pathogen adapted for intracellular survival.
Open AccessSILAKin: A novel high throughput SILAC and mass spectrometry-based assay to identify the substratome of kinases secreted by pathogens
Protein phosphorylation is one of the most important reversible post-translational modifications. It affects every cellular process including differentiation, metabolism and cell cycle. Eukaryotic protein kinases (ePK) catalyse the transfer of a phosphate from ATP onto proteins, which regulates fast changes in protein activity, structure or subcellular localisation. The systematic identification of substrates is thus crucial to characterise the functions of kinases and determine the pathways they regulate, and even more so when studying the impact of pathogens-excreted kinases on the host cell signal transduction. Several strategies and approaches have been used to identify substrates, but all show important limitations thus calling for the development of new efficient and more convenient approaches for kinase substrate identification. Herein, we present SILAkin, a novel and easy method to identify substrates that is applicable to most kinases. It combines phosphatase treatment, pulse heating, in vitro kinase assay (IVKA) and SILAC (Stable Isotope Labeling with Amino acids in Cell culture)-based quantitative mass spectrometry (MS). We developed SILAkin using the Leishmania casein kinase 1 (L-CK1.2) as experimental model. Leishmania , an intracellular parasite causing Leishmaniasis, releases L-CK1.2 in its host cell. Applying this novel assay allowed us to gain unprecedented insight into host-pathogen interactions through the identification of host substrates phosphorylated by pathogen-excreted kinases. We identified 225 substrates, including 85% previously unknown that represent novel mammalian CK1 targets, and defined a novel CK1 phosphorylation motif. The substratome was validated experimentally by L-CK1.2 and human CK1δ, demonstrating the efficiency of SILAkin to identify new substrates and revealing novel regulatory pathways. Finally, SILAkin was instrumental in highlighting host pathways potentially regulated by L-CK1.2 in Leishmania- infected host cells, described by the GO terms ‘viral & symbiotic interaction’, ‘apoptosis’, ‘actin cytoskeleton organisation’, and ‘RNA processing and splicing’. SILAkin thus can generate important mechanistic insights into the signalling of host subversion by these parasites and other microbial pathogen adapted for intracellular survival.
- Open Access
- 22 March 2021
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 11
Dangerous Duplicity: The Dual Functions of Casein Kinase 1 in Parasite Biology and Host Subversion
Casein Kinase 1 (CK1) family members are serine/threonine protein kinases that are involved in many biological processes and highly conserved in eukaryotes from protozoan to humans. Even though pathogens exploit host CK1 signaling pathways to survive, the role of CK1 in infectious diseases and host/pathogen interaction is less well characterized compared to other diseases, such as cancer or neurodegenerative diseases. Here we present the current knowledge on CK1 in protozoan parasites highlighting their essential role for parasite survival and their importance for host-pathogen interactions. We also discuss how the dual requirement of CK1 family members for parasite biological processes and host subversion could be exploited to identify novel antimicrobial interventions.
- 22 March 2021
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 11
Open AccessDangerous Duplicity: The Dual Functions of Casein Kinase 1 in Parasite Biology and Host Subversion
Casein Kinase 1 (CK1) family members are serine/threonine protein kinases that are involved in many biological processes and highly conserved in eukaryotes from protozoan to humans. Even though pathogens exploit host CK1 signaling pathways to survive, the role of CK1 in infectious diseases and host/pathogen interaction is less well characterized compared to other diseases, such as cancer or neurodegenerative diseases. Here we present the current knowledge on CK1 in protozoan parasites highlighting their essential role for parasite survival and their importance for host-pathogen interactions. We also discuss how the dual requirement of CK1 family members for parasite biological processes and host subversion could be exploited to identify novel antimicrobial interventions.
- 1 January 2021
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 210, 112956
In vitro identification of imidazo[1,2-a]pyrazine-based antileishmanial agents and evaluation of L. major casein kinase 1 inhibition
- 1 January 2021
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 210, 112956
In vitro identification of imidazo[1,2-a]pyrazine-based antileishmanial agents and evaluation of L. major casein kinase 1 inhibition